EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 213 / Numéro 3-4 (2019) Biologie Aujourd’hui, 213 3-4 (2019) 87-108 Références
Accès gratuit
Numéro
Biologie Aujourd’hui
Volume 213, Numéro 3-4, 2019
Page(s) 87 - 108
DOI https://doi.org/10.1051/jbio/2019026
Publié en ligne 12 décembre 2019
  • Ahmed, S.S., Schur, P.H., Macdonald, N.E., Steinman, L. (2014). Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun, 50 1-11. [CrossRef] [PubMed] [Google Scholar]
  • Aldrich, M.S. (1993). The neurobiology of narcolepsy-cataplexy. Prog Neurobiol, 41, 533-541. [CrossRef] [PubMed] [Google Scholar]
  • Aldrich, M.S., Hollingsworth, Z., Penney, J.B. (1992). Dopamine-receptor autoradiography of human narcoleptic brain. Neurology, 42, 410-415. [Google Scholar]
  • Aldrich, M.S., Prokopowicz, G., Ockert, K., Hollingsworth, Z., Penny, J.B., Albin, R.L. (1994). Neurochemical studies of human narcolepsy: Alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem. Sleep, 17, 598-608. [PubMed] [Google Scholar]
  • Andlauer, O., Moore, I.V.H., Jouhier, L., Drake, C., Peppard, P.E., Han, F., Hong, S.H., Poli, F., Plazzi, G., O’Hara, R., Haffen, E., Roth, T., Young, T., Mignot, E. (2013). Nocturnal REM sleep latency for identifying patients with narcolepsy/hypocretin deficiency. JAMA Neurol, 70, 891-902. [Google Scholar]
  • Aran, A., Lin, L., Nevsimalova, S., Plazzi, G., Hong, S.C., Weiner, K., Zeitzer, J., Mignot, E. (2009). Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep, 32, 979-983. [PubMed] [Google Scholar]
  • Aran, A., Weiner, K., Lin, L., Finn, L.A., Greco, M.A., Peppard, P., Young, T., Ofran, Y., Mignot, E. (2010). Post-streptococcal auto-antibodies inhibit protein disulfide isomerase and are associated with insulin resistance. PLoS One, 5, e12875. [CrossRef] [PubMed] [Google Scholar]
  • Aran, A., Lin, L., Finn, L.A., Weiner, K., Peppard, P., Young, T., Mignot, E. (2011). Post-streptococcal antibodies are associated with metabolic syndrome in a population-based cohort. PLoS One, 6, e25017. [CrossRef] [PubMed] [Google Scholar]
  • Aserinski, E., Kleitman, N. (1953). Regularly occuring periods of eye motility, and concomitant phenomena, during sleep. Science, 118, 273-274. [Google Scholar]
  • Baker, T.L., Foutz, A.S., McNerney, V., Mitler, M.M., Dement, W.C. (1982). Canine model of narcolepsy: Genetic and developmental determinants. Exp Neurol, 75, 729-742. [CrossRef] [PubMed] [Google Scholar]
  • Bardage, C., Persson, I., Ortqvist, A., Bergman, U., Ludvigsson, J.F., Granath, F. (2011). Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ, 343, d5956. [Google Scholar]
  • Bårdsen, K., Gjerstad, M.D., Partinen, M., Kvivik, I., Tjensvoll, A.B., Ruoff, P., Omdal, R., Brede, C. (2019). Considerably lower levels of hypocretin-1 in cerebrospinal fluid is revealed by a novel mass spectrometry method compared with standard radioimmunoassay. Anal Chem, 91, 9323-9329. [CrossRef] [PubMed] [Google Scholar]
  • Barker, C.I., Snape, M.D. (2014). Pandemic influenza A H1N1 vaccines and narcolepsy: Vaccine safety surveillance in action. Lancet Infect Dis, 14, 227-238. [CrossRef] [PubMed] [Google Scholar]
  • Behar, E., Lin, X., Grumet, F.C., Mignot, E. (1995). A new DRB1*1202 allele (DRB1*12022) found in association with DQA1*0102 and DQB1*0602 in two black narcoleptic subjects. Immunogenetics, 41, 52. [CrossRef] [PubMed] [Google Scholar]
  • Belongia, E.A., Irving, S.A., Waring, S.C., Coleman, L.A., Meece, J.K., Vandermause, M., Lindstrom, S., Kempf, D., Shay, D.K. (2010). Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008–2009 (H1N1), and 2007–2008 (H3N2) infections. JAMA, 304, 1091-1098. [CrossRef] [PubMed] [Google Scholar]
  • Bernard-Valnet, R., Yshii, L., Queriault, C., Nguyen, X.H., Arthaud, S., Rodrigues, M., Canivet, A., Morel, A.L., Matthys, A., Bauer, J., Pignolet, B., Dauvilliers, Y., Peyron, C., Liblau, R.S. (2016). CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci USA, 113, 10956-10961. [CrossRef] [Google Scholar]
  • Billiard, M., Seignalet, J. (1985). Extraordinary assoication between HLA-DR2 and narcolepsy. Lancet, 1, 226-227. [Google Scholar]
  • Billiard, M., Laaberki, M., Reygrobellet, C., Seignalet, J., Brissaud, L., Besset A. (1989). Elevated antibodies to streptococcal antigens in narcoleptic subjects. Sleep Res, 18(18), 201. [Google Scholar]
  • Black, J.L. 3rd, Silber, M.H., Krahn, L.E., Avula, R., Walker, D.L., Pankratz, V.S., Fredrickson, P.A., Slocumb, N.L. (2005a). Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry, 58, 504-509. [CrossRef] [PubMed] [Google Scholar]
  • Black, J.L. 3rd, Silber, M.H., Krahn, L.E., Fredrickson, P.A., Pankratz, V.S., Avula, R., Walker, D.L., Slocumb, N.L. (2005b). Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Sleep, 28, 427-431. [PubMed] [Google Scholar]
  • Boehme, R., Baker, T., Mefford, I., Barchas, J., Dement, W.C., Ciaranello, R. (1984). Narcolepsy: Cholinergic receptor changes in an animal model. Life Sci, 34, 1825-1828. [CrossRef] [PubMed] [Google Scholar]
  • Bowersox, S., Kilduff, T., Faul, K., Dement, W.C., Ciaranello, R.D. (1987). Brain dopamine receptor levels elevated in canine narcolepsy. Brain Res, 402, 44-48. [CrossRef] [PubMed] [Google Scholar]
  • Broadbent, A.J., Subbarao, K. (2011). Influenza virus vaccines: Lessons from the 2009 H1N1 pandemic. Curr Opin Virol, 1, 254-262. [CrossRef] [PubMed] [Google Scholar]
  • Cardoso, F. (2011). Sydenham’s chorea. Handb Clin Neurol, 100, 221-229. [Google Scholar]
  • Carlander, B., Eliaou, J.F., Billiard, M. (1993). Autoimmune hypothesis in narcolepsy. Neurophysiol Clin, 23, 15-22. [Google Scholar]
  • Carskadon, M.A., Dement, W.C., Mitler, M.M., Roth, T., Westbrook, P.R., Keenan, S. (1986). Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness. Sleep, 9, 519-524. [PubMed] [Google Scholar]
  • Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Fitch T.E., Nakazato, M., Hammer, R.E., Saper, C.B., Yanagisawa, M. (1999). Narcolepsy in orex in knockout mice: molecular genetics of sleep regulation. Cell, 98, 437-451. [CrossRef] [PubMed] [Google Scholar]
  • Cooper, J.D., Smyth, D.J., Smiles, A.M., Plagnol, V., Walker, N.M., Allen, J.E., Downes, K., Barrett, J.C., Healy, B.C., Mychaleckyj, J.C., Warram, J.H., Todd, J.A. (2008). Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet, 40, 1399-1401. [Google Scholar]
  • Crocker, A., Espana, R.A., Papadopoulou, M., Saper, C.B., Faraco, J., Sakurai, T., Honda, M., Mignot, E., Scammell, T.E. (2005). Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology, 65, 1184-1186. [Google Scholar]
  • Cvetkovic-Lopes, V., Bayer, L., Dorsaz, S., Maret, S., Pradervand, S., Dauvilliers, Y., Lecendreux, M., Lammers, G.J., Donjacour, C.E., Du Pasquier, R.A., Pfister, C., Petit, B., Hor, H., Mühlethaler, M., Tafti, M. (2010). Elevated tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest, 120, 713-719. [CrossRef] [PubMed] [Google Scholar]
  • Daniels, L. (1934). Narcolepsy. Medicine, 13, 1-122. [Google Scholar]
  • Dausset, J. (1972). Correlation between histocompatibility antigens and susceptibility to illness. Progr Clin Immunol, 1, 183-210. [Google Scholar]
  • Dauvilliers, Y., Carlander, B., Rivier, F., Touchon, J., Tafti, M. (2004). Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol, 56, 905-908. [CrossRef] [PubMed] [Google Scholar]
  • Dauvilliers, Y., Abril, B., Mas, E., Michel, F., Tafti, M. (2009). Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology, 73, 1333-1334. [Google Scholar]
  • Dauvilliers, Y., Montplaisir, J., Cochen, V., Desautels, A., Einen, M., Lin, L., Kawashima, M., Bayard, S., Monaca, C., Tiberge, M., Filipini, D., Tripathy, A., Nguyen, B.H., Kotagal, S., Mignot, E. (2010). Post-H1N1 narcolepsy-cataplexy. Sleep, 33, 1428-1430. [PubMed] [Google Scholar]
  • Dauvilliers, Y., Arnulf, I., Lecendreux, M., Monaca Charley, C., Franco, P., Drouot, X., d’Ortho, M.P., Launois, S., Lignot, S., Bourgin, P., Nogues, B., Rey, M., Bayard, S., Scholz, S., Lavault, S., Tubert-Bitter, P., Saussier, C., Pariente, A., Narcoflu-VF study group. (2013). Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain, 136, 2486-2496. [CrossRef] [PubMed] [Google Scholar]
  • De la Herran-Arita, A.K., Kornum, B.R., Mahlios, J., Jiang, W., Lin, L., Hou, T., Macaubas, C., Einen, M., Plazzi, G., Crowe, C., Newell, E.W., Davis, M.M., Mellins, E.D., Mignot, E. (2013). CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy. Sci Translat Med, 5, 216ra176. [CrossRef] [Google Scholar]
  • De Lecea, L., Kilduff, T.S., Peyron, C., Gao, X.-B., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L.F., Gautvik, V.T., Barlett, F.S., Frankel, W.N., Van Den Pol, A.N., Bloom, F.E., Gautvik, K.M., Sutcliffe, J.G. (1998). The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA, 95, 322-327. [CrossRef] [Google Scholar]
  • Dean, R.R., Kilduff, T.S., Dement, W.C., Grumet, F.C. (1989). Narcolepsy without unique MHC class II antigen association: Studies in the canine model. Hum Immunol, 25, 27-35. [CrossRef] [PubMed] [Google Scholar]
  • Dement, W., Wolpert, E.A. (1958). The relation of eye movement, body motility, and external stimuli to dream content. J Exper Psychol, 55, 543-553. [CrossRef] [Google Scholar]
  • Dement, W.C. (1990). A personal history of sleep disorders medicine. J Clin Neurophysiol, 7, 17-47. [Google Scholar]
  • Dement, W.C. (1993). The history of narcolepsy and other sleep disorders. J Hist Neurosci, 2, 121-134. [Google Scholar]
  • Dement, W.C., Carskadon, M., Ley, R. (1973). The prevalence of narcolepsy II. Sleep Res, 2, 147. [Google Scholar]
  • Dodd, C.N., de Ridder, M., Huang, W.T., Weibel, D., Giner-Soriano, M., Perez-Vilar, S., Diez-Domingo, J., Svenson, L.W., Mahmud, S.M., Carleton, B., Naus, M., Kwong, J.C., Murray, B.J., Arnheim-Dahlstrom, L., Pedersen, L., Morros, R., Puertas, F.J., Black, S., Sturkenboom, M. (2018). Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study. PLoS One, 13, e0204799. [CrossRef] [PubMed] [Google Scholar]
  • Dougherty, J.D., Schmidt, E.F., Nakajima, M., Heintz, N. (2010). Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res, 38, 4218-4230. [PubMed] [Google Scholar]
  • Dye, T.J., Gurbani, N., Simakajornboon, N. (2018). Epidemiology and pathophysiology of childhood narcolepsy. Paediatr Respir Rev, 25, 14-18. [Google Scholar]
  • Edwards, K., Hanquet, G., Black, S., Mignot, E., Jankosky, C., Shimabukuro, T., Miller, E., Nohynek, H., Neels, P. (2019). Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting. Biologicals, 60, 1-7. [CrossRef] [PubMed] [Google Scholar]
  • Ellis, M.C., Hetisimer, A.H., Ruddy, D.A., Hansen, S.L., Kronmal, G.S., McClelland, E., Quintana, L., Drayna, D.T., Aldrich, M.S., Mignot, E. (1997). HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics, 46, 410-417. [CrossRef] [PubMed] [Google Scholar]
  • Eriksson, K.S., Mignot, E. (2009). T-box 3 is expressed in the adult mouse hypothalamus and medulla. Brain Res, 1302, 233-239. [CrossRef] [PubMed] [Google Scholar]
  • Faraco, J., Lin, L., Kornum, B.R., Kenny, E.E., Trynka, G., Einen, M., Rico, T.J., Lichtner, P., Dauvilliers, Y., Arnulf, I., Lecendreux, M., Javidi, S., Geisler, P., Mayer, G., Pizza, F., Poli, F., Plazzi, G., Overeem, S., Lammers, G.J., Kemlink, D., Sonka, K., Nevsimalova, S., Rouleau, G., Desautels, A., Montplaisir, J., Frauscher, B., Ehrmann, L., Högl, B., Jennum, P., Bourgin, P., Peraita-Adrados, R., Iranzo, A., Bassetti, C., Chen, W.M., Concannon, P., Thompson, S.D., Damotte, V., Fontaine, B., Breban, M., Gieger, C., Klopp, N., Deloukas, P., Wijmenga, C., Hallmayer, J., Onengut-Gumuscu, S., Rich, S.S., Winkelmann, J., Mignot, E. (2013). ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet, 9, e1003270. [CrossRef] [PubMed] [Google Scholar]
  • Faull, K.F., Zeller-DeAmicis, L.C., Radde, L., Bowersox, S.S., Baker, T.L., Kilduff, T.S., Dement, W.C. (1986). Biogenic amine concentrations in the brains of normal and narcoleptic canines: current status. Sleep, 9, 107-110. [PubMed] [Google Scholar]
  • Fernandez-Vina, M., Moraes, J.R., Moraes, M.E., Miller, S., Stasny, P. (1991). HLA class II haplotypes in Amerindians and in black North and South Americans. Tissue Antigens, 38, 235-237. [PubMed] [Google Scholar]
  • Foutz, A., Mitler, M., Cavalli-Sforza, L., Dement, W.C. (1979). Genetic factors in canine narcolepsy. Sleep, 1, 413-421. [CrossRef] [PubMed] [Google Scholar]
  • Fronczek, R., Verschuuren, J., Lammers, G.J. (2007). Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol, 254, 1607-1608. [CrossRef] [PubMed] [Google Scholar]
  • Gautvik, K.M., de Lecea, L., Gautvik, V.T., Danielson, P.E., Tranque, P., Dopazo, A., Bloom, F.E., Sutcliffe, J.G. (1996). Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA, 93, 8733-8738. [CrossRef] [Google Scholar]
  • Gélineau, J.B.E. (1880). De la narcolepsie. Gazette des Hôpitaux, 53, 626-628. [Google Scholar]
  • Guilleminault, C., Grumet, C. (1986). HLA-DR2 and narcolepsy: Not all narcoleptic-cataplectic patients are DR2. Hum Immunol, 17, 1-2. [CrossRef] [PubMed] [Google Scholar]
  • Guilleminault, C., Holloman, J., Grumet, C., Kilduff, T., McDevitt, H.O., Dement, W.C., MItler, M.M. HLA-DR2 and the narcolepsy syndrome: The Stanford experience, in: Y. Honda, T. Juji (Eds.), HLA in narcolepsy, New York, 1988, pp. 108-113. [CrossRef] [Google Scholar]
  • Guilleminault, C., Mignot, E., Grumet, F.C. (1989). Familial patterns of narcolepsy. Lancet, 2, 1376-1379. [CrossRef] [PubMed] [Google Scholar]
  • Hallmayer, J., Faraco, J., Lin, L., Hesselson, S., Winkelmann, J., Kawashima, M., Mayer, G., Plazzi, G., Nevsimalova, S., Bourgin, P., Hong, S.C., Honda, Y., Honda M., Högl B., Longstreth, W.T. Jr., Montplaisir, J., Kemlink, D., Einen, M., Chen, J., Musone, S.L., Akana, M., Miyagawa, T., Duan, J., Desautels, A., Erhardt, C., Hesla, P.E., Poli, F., Frauscher, B., Jeong J.H., Lee, S.P., Ton, T.G., Kvale, M., Kolesar, L., Dobrovolná, M., Nepom, G.T., Salomon, D., Wichmann, H.E., Rouleau, G.A., Gieger, C., Levinson, D.F., Gejman, P.V., Meitinger, T., Young, T., Peppard, P., Tokunaga, K., Kwok, P.Y., Risch, N., Mignot, E. (2009). Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet, 41, 708-711. [Google Scholar]
  • Han, F., Lin, L., Li, J., Aran, A., Dong, S.X., An, P., Zhao, L., Li, M., Li, Q.Y., Yan, H., Wang, J.S., Gao, H.Y., Li, M., Gao, Z.C., Strohl, K.P., Mignot, E. (2011a). Presentations of primary hypersomnia in chinese children. Sleep, 34, 627-632. [PubMed] [Google Scholar]
  • Han, F., Lin, L., Warby, S.C., Faraco, J., Li, J., Dong, S.X., An, P., Zhao, L., Wang, L.H., Li, Q.Y., Yan, H., Gao, Z.C., Yuan, Y., Strohl, K.P., Mignot, E. (2011b). Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol, 70, 410-417. [CrossRef] [PubMed] [Google Scholar]
  • Han, F., Lin, L., Li, J., Dong, S.X., An, P., Zhao, L., Liu, N.Y., Li, Q.Y., Yan, H., Gao, Z.C., Faraco, J., Strohl, K.P., Liu, X., Miyadera, H., Mignot, E. (2012a). HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens, 80, 328-335. [PubMed] [Google Scholar]
  • Han, F., Lin, L., Li, J., Dong, X.S., Mignot, E. (2012b). Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol, 73, 560. [CrossRef] [PubMed] [Google Scholar]
  • Han, F., Faraco, J., Dong, X.S., Ollila, H.M., Lin, L., Li, J., An, P., Wang, S., Jiang, K.W., Gao, Z.C., Zhao, L., Yan, H., Liu, Y.N., Li, Q.H., Zhang, X.Z., Hu, Y., Wang, J.Y., Lu, Y.H., Lu, C.J., Zhou, W., Hallmayer, J., Huang, Y.S., Strohl, K.P., Pollmächer, T., Mignot, E. (2013). Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet, 9, e1003880. [CrossRef] [PubMed] [Google Scholar]
  • Han, F., Schormair, B., Pizza, F., Ollila, H.M., Nevsimalova, S., Jennum, P., Knudsen, S., Winkelmann, J., Coquillard, C., Babzardeh, F., Strom, T.M., Wang, C., Mindrinos, M., Fernandez Vina, M., Mignot, E., (2014). HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep, 37, 1601-1608. [PubMed] [Google Scholar]
  • Hecht, M., Lin, L., Kushida, C.A., Umetsu, D.T., Taheri, S., Einen, M., Mignot, E. (2003). Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Sleep, 26, 809-810. [PubMed] [Google Scholar]
  • Heier, M.S., Gautvik, K.M., Wannag, E., Bronder, K.H., Midtlyng, E., Kamaleri, Y., Storsaeter, J. (2013). Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med, 14, 867-871. [CrossRef] [PubMed] [Google Scholar]
  • Hirota, T., Takahashi, A., Kubo, M., Tsunoda, T., Tomita, K., Sakashita, M., Yamada, T., Fujieda, S., Tanaka, S., Doi, S., Miyatake, A., Enomoto, T., Nishiyama, C., Nakano, N., Maeda, K., Okumura, K., Ogawa, H., Ikeda, S., Noguchi, E., Sakamoto, T., Hizawa, N., Ebe, K., Saeki, H., Sasaki, T., Ebihara, T., Amagai, M., Takeuchi, S., Furue, M., Nakamura, Y., Tamari, M. (2012). Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat Genet, 44, 1222-1226. [Google Scholar]
  • Hohjoh, H., Terada, N., Honda, Y., Juji, T., Tokunaga, K. (2001). Negative association of the HLA-DRB1*1502-DQB1*0601 haplotype with human narcolepsy. Immunogenetics, 52, 299-301. [CrossRef] [PubMed] [Google Scholar]
  • Honda, M., Eriksson, K.S., Zhang, S., Tanaka, S., Lin, L., Salehi, A., Hesla, P.E., Maehlen, J., Gaus, S.E., Yanagisawa, M., Sakurai, T., Taheri, S., Tsuchiya, K., Honda, Y., Mignot, E. (2009). IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS One, 4, e4254. [CrossRef] [PubMed] [Google Scholar]
  • Honda, Y. Clinical features of narcolepsy: Japanese experience. In: Y. Honda, T. Juji (Eds.), “HLA in Narcolepsy”, Sringer-Verlag, New York, 1988a, pp. 24-57. [Google Scholar]
  • Honda, Y. Introduction to HLA in Narcolepsy. In: Y. Honda, T. Juji (Eds.), “HLA in Narcolepsy”, Springer-Verlag, New York, 1988b, pp. 1-10. [Google Scholar]
  • Honda, Y., Asaka, C., Tanimura, M., Furusho, T. A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband. In: C. Guilleminault, E. Lugaresi (Eds.), “Sleep/wake disorders: Natural history, epidemiology and long-term evolution”, Raven Press, New York, 1983a, pp. 187-199. [Google Scholar]
  • Honda, Y., Asake, A., Tanaka, Y., Juji, T. (1983b). Discrimination of narcolepsy by using genetic markers and HLA. Sleep Res, 12, 154. [Google Scholar]
  • Hong, S.C., Lin, L., Lo, B., Jeong, J.H., Shin, Y.K., Kim, S.Y., Kweon, Y., Zhang, J., Einen, M., Smith, A., Hansen, J., Grumet, F.C., Mignot, E. (2007). DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans. Hum Immunol, 68, 59-68. [CrossRef] [PubMed] [Google Scholar]
  • Hor, H., Kutalik, Z., Dauvilliers, Y., Valsesia, A., Lammers, G.J., Donjacour, C.E., Iranzo, A., Santamaria, J., Peraita Adrados, R., Vicario, J.L., Overeem, S., Arnulf, I., Theodorou, I., Jennum, P., Knudsen, S., Bassetti, C., Mathis, J., Lecendreux, M., Mayer, G., Geisler, P., Benetó, A., Petit, B., Pfister, C., Bürki, J.V., Didelot, G., Billiard, M., Ercilla, G., Verduijn, W., Claas, F.H., Vollenweider, P., Waeber, G., Waterworth, D.M., Mooser, V., Heinzer, R., Beckmann, J.S., Bergmann, S., Tafti, M. (2010). Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet, 42, 786-789. [Google Scholar]
  • Huang, W.T., Huang, Y.S., Hsu, C.Y., Chen, H.C., Lee, H.C., Lin, H.C., Hsieh, C.F., Wu, M.N., Yang, C.H. (2018). Narcolepsy and 2009 H1N1 pandemic vaccination in Taiwan. Sleep Med. DOI: 10.1016/j.sleep.2018.10.036. [Google Scholar]
  • Jackson, M.W., Reed, J.H., Smith, A.J., Gordon, T.P. (2008). An autoantibody in narcolepsy disrupts colonic migrating motor complexes. J Neurosci, 28, 13303-13309. [CrossRef] [PubMed] [Google Scholar]
  • Jacob, L., Leib, R., Ollila, H.M., Bonvalet, M., Adams, C.M., Mignot, E. (2015). Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun, 47, 44-57. [CrossRef] [PubMed] [Google Scholar]
  • Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson, C.A., Essers, J., Mitrovic, M., Ning, K., Cleynen, I., Theatre, E., Spain, S.L., Raychaudhuri, S., Goyette, P., Wei, Z., Abraham, C., Achkar, J.P., Ahmad, T., Amininejad, L., Ananthakrishnan, A.N., Andersen, V., Andrews, J.M., Baidoo, L., Balschun, T., Bampton, P.A., Bitton, A., Boucher, G., Brand, S., Büning, C., Cohain, A., Cichon, S., D’Amato, M, De Jong, D., Devaney, K.L., Dubinsky, M., Edwards, C., Ellinghaus, D., Ferguson, L.R., Franchimont, D., Fransen, K., Gearry, R., Georges, M., Gieger, C., Glas, J., Haritunians, T., Hart, A., Hawkey, C., Hedl, M., Hu, X., Karlsen, T.H., Kupcinskas, L., Kugathasan, S., Latiano, A., Laukens, D., Lawrance, I.C., Lees, C.W., Louis, E., Mahy, G., Mansfield, J., Morgan, A.R., Mowat, C., Newman, W., Palmieri, O., Ponsioen, C.Y., Potocnik, U., Prescott, N.J., Regueiro, M., Rotter, J.I., Russell, R.K., Sanderson, J.D., Sans, M., Satsangi, J., Schreiber, S., Simms, L.A., Sventoraityte, J., Targan, S.R., Taylor, K.D., Tremelling, M., Verspaget, H.W., De Vos, M., Wijmenga, C., Wilson, D.C., Winkelmann, J., Xavier, R.J., Zeissig, S., Zhang, B., Zhang, C.K., Zhao, H., International IBD Genetics Consortium (IIBDGC), Silverberg, M.S., Annese, V., Hakonarson, H., Brant, S.R., Radford-Smith, G., Mathew, C.G., Rioux, J.D., Schadt, E.E., Daly, M.J., Franke, A., Parkes, M., Vermeire, S., Barrett, J.C., Cho, J.H. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491, 119-124. [Google Scholar]
  • Jouvet, M. (1962). Recherche sur les structures nerveuses et les mecanismes responsables des differentes phases du sommeil physiologique. Arch Itali Biol, 100, 125-206. [Google Scholar]
  • Juji, T., Satake, M., Honda, Y., Doi, Y. (1984). HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens, 24, 316-319. [CrossRef] [PubMed] [Google Scholar]
  • Kadotani, H., Faraco, J., Mignot, E. (1998). Genetic studies in the sleep disorder narcolepsy. Genome Res, 8, 427-434. [CrossRef] [PubMed] [Google Scholar]
  • Karczmar, A.G., Longo, V.G., De Carolis, S. (1970). A pharmacological model of paradoxical sleep: the role of cholinergic and monoaminergic systems. Physiol Behav, 5, 175-182. [CrossRef] [PubMed] [Google Scholar]
  • Katzav, A., Arango, M.T., Kivity, S., Tanaka, S., Givaty, G., Agmon-Levin, N., Honda, M., Anaya, J.M., Chapman, J., Shoenfeld, Y. (2013). Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J Autoimmun, 45, 24-30. [CrossRef] [PubMed] [Google Scholar]
  • Kilduff, T., Bowersox, S.S., Kaitin, K.I., Baker, T.L., Ciaranello, R.D., Dement, W.C. (1986). Muscarinic cholinergic receptors and the canine model of narcolepsy. Sleep, 9, 102-107. [PubMed] [Google Scholar]
  • Kim, K., Bang, S.Y., Lee, H.S., Cho, S.K., Choi, C.B., Sung, Y.K., Kim, T.H., Jun, J.B., Yoo, D.H., Kang, Y.M., Kim, S.K., Suh, C.H., Shim, S.C., Lee, S.S., Lee, J., Chung, W.T., Choe, J.Y., Shin, H.D., Lee, J.Y., Han, B.G., Nath, S.K., Eyre, S., Bowes, J., Pappas, D.A., Kremer, J.M., Gonzalez-Gay, M.A., Rodriguez-Rodriguez, L., Ärlestig, L., Okada, Y., Diogo, D., Liao, K.P., Karlson, E.W., Raychaudhuri, S., Rantapää-Dahlqvist, S., Martin, J., Klareskog, L., Padyukov, L., Gregersen, P.K., Worthington, J., Greenberg, J.D., Plenge, R.M., Bae, S.C. (2014). High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. Ann Rheum Dis, 74, e13. [CrossRef] [PubMed] [Google Scholar]
  • Knecht, C.D., Oliver, J.E., Redding, R., Selcer, R., Johnson, G. (1973). Narcolepsy in a dog and a cat. J Am Vet Med Assoc, 162, 1052-1053. [PubMed] [Google Scholar]
  • Knudsen, S., Mikkelsen, J.D., Jennum, P. (2007). Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons. Neuroreport, 18, 77-79. [CrossRef] [PubMed] [Google Scholar]
  • Knudsen, S., Biering-Sorensen, B., Kornum, B.R., Petersen, E.R., Ibsen, J.D., Gammeltoft, S., Mignot, E., Jennum, P.J. (2012). Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency. Neurology, 79, 102-103. [Google Scholar]
  • Koepsell, T.D., Longstreth, W.T., Ton, T.G. (2009). Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people. J Sleep Res, 19, 80-86. [CrossRef] [PubMed] [Google Scholar]
  • Kornum, B.R., Kawashima, M., Faraco, J., Lin, L., Rico, T., Hesselson, S., Axtell, R.C., Kuipers, H., Weiner, K., Hamacher, A., Kassack, M.U., Han, F., Knudsen, S., Li, J., Dong, X., Winkelmann, J., Plazzi, G., Nevsimalova, S., Hong, S.C., Honda, Y., Honda, M., Högl, B., Ton, T.G., Montplaisir, J., Bourgin, P., Kemlink, D., Huang, Y.S., Warby, S., Einen, M., Eshragh, J.L., Miyagawa, T., Desautels, A., Ruppert, E., Hesla, P.E., Poli, F., Pizza, F., Frauscher, B., Jeong, J.H., Lee, S.P., Strohl, K.P., Longstreth, W.T. Jr, Kvale, M., Dobrovolna, M., Ohayon, M.M., Nepom, G.T., Wichmann, H.E., Rouleau, G.A., Gieger, C., Levinson, D.F., Gejman, P.V., Meitinger, T., Peppard, P., Young, T., Jennum, P., Steinman, L., Tokunaga, K., Kwok, P.Y., Risch, N., Hallmayer, J., Mignot, E. (2011). Common variants in P2RY11 are associated with narcolepsy. Nat Genet, 43, 66-71. [Google Scholar]
  • Kushida, C.A., Baker, T.L., Dement, W.C. (1985). Electroencephalographic correlates of cataplectic attacks in narcoleptic canines. Electro Clin Neurophysiol, 61, 61-70. [CrossRef] [Google Scholar]
  • Latorre, D., Kallweit, U., Armentani, E., Foglierini, M., Mele, F., Cassotta, A., Jovic, S., Jarrossay, D., Mathis, J., Zellini, F., Becher, B., Lanzavecchia, A., Khatami, R., Manconi, M., Tafti, M., Bassetti, C.L., Sallusto, F. (2018). T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature, 562, 63-68. [Google Scholar]
  • Li, R., Faraco, J.H., Lin, L., Lin, X., Hinton, L., Rogers, W., Lowe, J.K., Ostrander, E.A., Mignot, E. (2001). Physical and radiation hybrid mapping of canine chromosome 12, in a region corresponding to human chromosome 6p12-q12. Genomics, 73, 299-315. [CrossRef] [PubMed] [Google Scholar]
  • Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S., Mignot, E. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98, 365-376. [CrossRef] [PubMed] [Google Scholar]
  • Lind, A., Ramelius, A., Olsson, T., Arnheim-Dahlstrom, L., Lamb, F., Khademi, M., Ambati, A., Maeurer, M., Nilsson, A.L., Bomfim, I.L., Fink, K., Lernmark, Å. (2014). A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009–2010. J Autoimmun, 50, 99-106. [CrossRef] [PubMed] [Google Scholar]
  • Lock, C.B., Welsh, K.I., Parkes, J.D., Briggs, D.C., Waughan, R.W., Van Dam, M. HLA in narcolepsy-cataplexy in the United Kingdom. In: Y. Honda, T. Juji (Eds.), “HLA in narcolepsy”, Springer-Verlag, New York, 1988, pp. 1041-1045. [Google Scholar]
  • Löwenfeld, L. (1902). Uber Narkolepsie. Munch Med Wochenschr, 49, 1041-1045. [Google Scholar]
  • Lucas, E.A., Foutz, A.S., Mitler, M.M., Brown, D., Dement, W.C. (1978). Multiple sleep latency test in normal and narcoleptic canines. Soc Neurosci Abstr, 6, 541. [Google Scholar]
  • Lucas, E.A., Foutz, A.S., Dement, W.C., Mitler, M.M. (1979). Sleep cycle organization in narcoleptic and normal dogs. Physiol Behav, 23, 737-743. [CrossRef] [PubMed] [Google Scholar]
  • Luo, G., Ambati, A., Lin, L., Bonvalet, M., Partinen, M., Ji, X., Maecker, H.T., Mignot, E. (2018). Autoimmunity to hypocretin and molecular mimicry to flu antigens in Type 1 narcolepsy. Proc Natl Acad Sci USA, 115, E12323-12332. [CrossRef] [Google Scholar]
  • Manku, H., Langefeld, C.D., Guerra, S.G., Malik, T.H., Alarcon-Riquelme, M., Anaya, J.M., Bae, S.C., Boackle, S.A., Brown, E.E., Criswell, L.A., Freedman, B.I., Gaffney, P.M., Gregersen, P.A., Guthridge, J.M., Han, S.H., Harley, J.B., Jacob, C.O., James, J.A., Kamen, D.L., Kaufman, K.M., Kelly, J.A., Martin, J., Merrill, J.T., Moser, K.L., Niewold, T.B., Park, S.Y., Pons-Estel, B.A., Sawalha, A.H., Scofield, R.H., Shen, N., Stevens, A.M., Sun, C., Gilkeson, G.S., Edberg, J.C., Kimberly, R.P., Nath, S.K., Tsao, B.P., Vyse, T.J. (2013). Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. PLoS Genet, 9, e1003554. [CrossRef] [PubMed] [Google Scholar]
  • Martinez-Rodriguez, J.E., Sabater, L., Graus, F., Iranzo, A., Santamaria, J. (2007). Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy. Sleep, 30, 27-28. [PubMed] [Google Scholar]
  • Matsuki, K., Grumet, F.C., Lin, X., Gelb, M., Guilleminault, C., Dement, W.C., Mignot, E. (1992). DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet, 339, 1052. [Google Scholar]
  • Matsuki, K., Honda, Y., Juji, T. (1987). Diagnostic criteria for narcolepsy and HLA-DR2 frequencies. Tissue Antigens, 30, 155-160. [PubMed] [Google Scholar]
  • Matsuki, K., Juji, T., Honda, Y. Immunological features of narcolepsy in Japan. In: Y. Honda, T. Juji (Eds.), “HLA in narcolepsy”, Springer-Verlag, New York, 1988, pp. 150-157. [Google Scholar]
  • McDevitt, H.O., Tyan, M.L. (1968). Genetic control of the antibody response in inbred mice. Transfer of response by spleen cells and linkage to the major histocompatibility (H-2) locus. J Exp Med, 128, 1-11. [CrossRef] [PubMed] [Google Scholar]
  • Mefford, I.N., Baker, T.L., Boehme, R., Foutz, A.S., Ciaranello, R.D., Barchas, J.D., Dement, W.C. (1983). Narcolepsy: Biogenic amine deficits in an animal model. Science, 220, 629-632. [Google Scholar]
  • Mignot, E. (1998). Genetic and familial aspects of narcolepsy. Neurology, 50, S16-22. [Google Scholar]
  • Mignot, E. (2008). Why we sleep: the temporal organization of recovery. PLoS Biol, 6, e106. [CrossRef] [PubMed] [Google Scholar]
  • Mignot, E., Wang, C., Rattazzi, C., Gaiser, C., Lovett, M., Guilleminault, C., Dement, W.C., Grumet, F.C. (1991). Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment. Proc Natl Acad Sci USA, 88, 3475-3478. [CrossRef] [Google Scholar]
  • Mignot, E., Guilleminault, C., Grumet, F.C., Dement, W.C. Is narcolepsy an autoimmune disease?. In: S. Smirne, M. Francesci, L. Ferini-Strambi, M. Zucconi (Eds.), Proceedings of the Third Milano International Symposium, September 18–19, “Sleep, Hormones, and the Immune System”, Masson, Milan, 1992, pp. 29-38. [Google Scholar]
  • Mignot, E., Lin, X., Hesla, P.E., Dement, W.C., Guilleminault, C., Grumet, F.C. (1993a). A novel HLA DR17, DQ1 (DQA1-0102/DQB1-0602 positive) haplotype predisposing to narcolepsy in Caucasians. Sleep, 16, 764-765. [PubMed] [Google Scholar]
  • Mignot, E., Renaud, A., Nishino, S., Arrigoni, J., Guilleminault, C., Dement, W.C. (1993b). Canine cataplexy is preferentially controlled by adrenergic mechanisms: Evidence using monoamine selective uptake inhibitors and release enhancers. Psychopharmacology, 113, 76-82. [CrossRef] [PubMed] [Google Scholar]
  • Mignot, E., Bell, R.A., Rattazzi, C., Lovett, M., Grumet, F.C., Dement, W.C. (1994a). An immunoglobulin switchlike sequence is linked with canine narcolepsy. Sleep, 17, S68-76. [PubMed] [Google Scholar]
  • Mignot, E., Lin, X., Arrigoni, J., Macaubas, C., Olive, F., Hallmayer, J., Underhill, P., Guilleminault, C., Dement, W.C., Grumet, F.C. (1994b). DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep, 17, S60-67. [PubMed] [Google Scholar]
  • Mignot, E., Nishino, S., Guilleminault, C., Dement, W.C. (1994c). Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep, 17, 436-437. [PubMed] [Google Scholar]
  • Mignot, E., Kimura, A., Lattermann, A., Lin, X., Yasunaga, S., Mueller-Eckhardt, G., Rattazzi, C., Lin, L., Guilleminault, C., Grumet, F.C., Mayer, G., Dement, W.C., Underhill, P. (1997). Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens, 49, 329-341. [PubMed] [Google Scholar]
  • Mignot, E., Lin, L., Rogers, W., Honda, Y., Qiu, X., Lin, X., Okun, M., Hohjoh, H., Miki, T., Hsu, S., Leffell, M., Grumet, F., Fernandez-Vina, M., Honda, M., Risch, N. (2001). Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet, 68, 686-699. [Google Scholar]
  • Mignot, E., Lammers, G.J., Ripley, B., Okun, M., Nevsimalova, S., Overeem, S., Vankova, J., Black, J., Harsh, J., Bassetti, C., Schrader, H., Nishino, S. (2002). The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol, 59, 1553-1562. [CrossRef] [PubMed] [Google Scholar]
  • Mignot, E., Lin, L., Li, H., Thomson, G., Lathrop, M., Thorsby, E., Tokunaga, K., Honda, Y., Dauvilliers, Y., Tafti, M.M., Billiard, G., Mayer, J., Montplaisir,G., Rouleau, H., Temple, M., Thorpy, B., Martins, A., Silva, M., Vazquez,C., Alaez, C., Gorodezky, G., Schoch, B., Lo, Grumet, F.C. 13th International Histocompatibility Working group for narcolepsy joint report. In: J. Hansen, B. Dupont (Eds.), “Immunobiology of Human MHC”, Proceedings of the 13th International Histocompatibility Workshop and Congress (Seattle, WA 2004), IHWG Press, Seattle, WA, USA, 2006, pp. 782-787. [Google Scholar]
  • Mignot, E.J. (2012). A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics, 9, 739-752. [Google Scholar]
  • Miller, E., Andrews, N., Stellitano, L., Stowe, J., Winstone, A.M., Shneerson, J., Verity, C. (2013). Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ, 346, f794. [Google Scholar]
  • Miller, J.D., Faull, K.F., Bowersox, S.S., Dement, W.C. (1990). CNS monoamines and their metabolites in canine narcolepsy: a replication study. Brain Res, 509, 169-171. [CrossRef] [PubMed] [Google Scholar]
  • Mitler, M.M., Boysen, B.G., Campbell, L., Dement, W.C. (1974). Narcolepsy-cataplexy in a female dog. Exp Neurol, 45, 332-340. [CrossRef] [PubMed] [Google Scholar]
  • Mitler, M.M., Dement, W.C. (1977). Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs. Electroencephalogr Clin Neurophysiol, 43, 691-699. [CrossRef] [PubMed] [Google Scholar]
  • Mitler, M.M., Van den Hoed, J., Carskadon, M.A., Richardson, G., Park, R., Guilleminault, C., Dement, W.C. (1979). REM sleep episodes during the Multple sleep latency test in narcoleptic patients. Electroencephalogr Clin Neurophysiol, 46, 479-481. [CrossRef] [PubMed] [Google Scholar]
  • Miyagawa, T., Toyoda, H., Hirataka, A., Kanbayashi, T., Imanishi, A., Sagawa, Y., Kotorii, N., Kotorii, T., Hashizume, Y., Ogi, K., Hiejima, H., Kamei, Y., Hida, A., Miyamoto, M., Imai, M., Fujimura, Y., Tamura, Y., Ikegami, A., Wada, Y., Moriya, S., Furuya, H., Kato, M., Omata, N., Kojima, H., Kashiwase, K., Saji, H., Khor, S.S., Yamasaki, M., Wada, Y., Ishigooka, J., Kuroda, K., Kume, K., Chiba, S., Yamada, N., Okawa, M., Hirata, K., Uchimura, N., Shimizu, T., Inoue, Y., Honda, Y., Mishima, K., Honda, M., Tokunaga, K. (2015). New susceptibility variants to narcolepsy identified in HLA class II region. Hum Mol Genet, 24, 891-898. [CrossRef] [PubMed] [Google Scholar]
  • Montplaisir, J., Poirier, G., HLA in narcolepsy in Canada. In: Y. Honda, T. Juji (Eds.), “HLA in narcolepsy”, Springer-Verlag, New York, 1988, pp. 97-107. [Google Scholar]
  • Montplaisir, J., Poirer, G., Lapierre, O., Montplaisir J. (1989). Streptococcal antibodies in narcolepsy and idiopathic hypersomnia. Sleep Res, 18, 271. [Google Scholar]
  • Moran, C.J., Walters, T.D., Guo, C.H., Kugathasan, S., Klein, C., Turner, D., Wolters, V.M., Bandsma, R.H., Mouzaki, M., Zachos, M., Langer, J.C., Cutz, E., Benseler, S.M., Roifman, C.M., Silverberg, M.S., Griffiths, A.M., Snapper, S.B., Muise, A.M. (2013). IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis, 19, 115-123. [CrossRef] [PubMed] [Google Scholar]
  • Moris, P., van der Most, R., Leroux-Roels, I., Clement, F., Drame, M., Hanon, E., Leroux-Roels, G.G., Van Mechelen, M. (2011). H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses. J Clin Immunol, 31, 443-454. [PubMed] [Google Scholar]
  • Motoyama, M., Kilduff, T.S., Lee, B.S.M., Dement, W.C., McDevitt, H.O. (1989). Restriction fragment length polymorphism in canine narcolepsy. Immunogenetics, 29, 124-126. [CrossRef] [PubMed] [Google Scholar]
  • Mueller-Eckhardt, G., Meier-Ewert, K., Schendel, D.J., Reinecker, F.B., Multhoff, G., Mueller-Eckhardt, C. (1986). HLA and narcolepsy in a German population. Tissue Antigens, 28, 163-169. [PubMed] [Google Scholar]
  • Mueller-Eckhardt, G., Meier-Ewart, K., Schiefer, H.G. (1990). Is there an infectious origin of narcolepsy? Lancet, 335, 424. [Google Scholar]
  • Neely, S.E., Rosenberg, R.S., Spire, J.P., Antel, J., Arnason, W. (1986). Familial narcolepsy and HLA antigens. Ann Neurol, 20, 168. [Google Scholar]
  • Nevsimalova, S., Mignot, E., Sonka, K., Arrigoni, J.L. (1997). Familial aspects of narcolepsy-cataplexy in the Czech Republic. Sleep, 20, 1021-1026. [PubMed] [Google Scholar]
  • Nishino, S., Arrigoni, J., Shelton, J., Dement, W.C., Mignot, E. (1993). Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compounds. Sleep, 16, 706-712. [PubMed] [Google Scholar]
  • Nishino, S., Mignot, E. (1997). Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol, 52, 27-78. [CrossRef] [PubMed] [Google Scholar]
  • Nishino, S., Mao, J., Sampathkumaran, R., Shelton, J. (1998). Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online, 1, 49-61. [PubMed] [Google Scholar]
  • Nishino, S., Ripley, B., Overeem, S., Lammers, G.J., Mignot, E. (2000). Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 355, 39-40. [CrossRef] [PubMed] [Google Scholar]
  • Nohynek, H., Jokinen, J., Partinen, M., Vaarala, O., Kirjavainen, T., Sundman, J., Himanen, S.L., Hublin, C., Julkunen, I., Olsen, P., Saarenpää-Heikkilä, O., Kilpi, T. (2012). AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One, 7, e33536. [CrossRef] [PubMed] [Google Scholar]
  • Oberle, D., Drechsel-Bauerle, U., Schmidtmann, I., Mayer, G., Keller-Stanislawski, B. (2015). Incidence of narcolepsy in Germany. Sleep, 38, 1619-1628. [PubMed] [Google Scholar]
  • Ohayon, M.M., Priest, R.G., Zulley, J., Smirne, S., Paiva, T. (2002). Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology, 58, 1826-1833. [Google Scholar]
  • Ollila, H.M., Fernandes-Vina, M., Mignot, E. (2014). HLA-DQ allele competition in narcolepsy: A comment on Tafti et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep, 38, 147-151 [Google Scholar]
  • Ollila, H.M., Ravel, J.M., Han, F., Faraco, J., Lin, L., Zheng, X., Plazzi, G., Dauvilliers, Y., Pizza, F., Hong, S.C., Jennum, P., Knudsen, S., Kornum, B.R., Dong, X.S., Yan, H., Hong, H., Coquillard, C., Mahlios, J., Jolanki, O., Einen, M., Arnulf, I., Högl, B., Frauscher, B., Crowe, C., Partinen, M., Huang, Y.S., Bourgin, P., Vaarala, O., Désautels, A., Montplaisir, J., Mack, S.J., Mindrinos, M., Fernandez-Vina, M., Mignot, E. (2015). HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet, 96, 136-146. [Google Scholar]
  • Ollila, H., Sharon, E., Lin, L., Sinnott-Armstrong, N., Ambati, A., Hillary, R.P., Jolanki, O., Faraco, J., Einen, M., Luo, G., Zhang, J., Han F., Yan, H., Dong, X.S., Li J., Hong, S.-C., Kim, T.W., Dauvilliers, Y., Barateau, L., Lammers, G.J., Fronczek, R., Mayer, G., Santamaria, J., Arnulf, I., Knudsen, S., Lyamouri-Bredahl, M.K., Thorsby, P.M., Plazzi, G., Pizza, F., Moresco, M., Crowe, C., Van-den-Eeden, S.K., Lecendreux, M., Bourgin, P., Kanbayashi, T., Peraita-Adrados, R., Martinez-Orozco, F.J., Beneto, A., Montplaisir, J., Desautels, A., Huang, Y.-S., Jennum, P., Nevsimalova, S., Kemlink, D., Iranzo, A., Overeem, S., Wierzbicka, A., Geisler, P., Sonka, K., Honda, M., Hogl, B., Frauscher, B., Stefani, A., Coelho, F.M., Mantovani, V., Feketeova, E., Wadelius, M., Eriksson, N., Smedje, H., Hallberg, P., Hesla, P.E., Rye, D., Pelin, Z., Ferini-Strambi, L., Bassetti, C.L., Mathis, J., Khatami, R., Aran, A., Nampoothiri, S., Olsson, T., Kockum, I., Partinen, M., Perola, M., Kornum, B.R., Rueger, S., Winkelmann, J., Miyagawa, T., Toyoda, H., Khor, S.S., Shimada, M., Tokunaga, K., Rivas, M., Pritchard, J.K., Risch, N., Kutalik, Z., Ohara, R., Hallmayer, J., Ye, J., Mignot, E. (2018). Narcolepsy risk loci are enriched in immune cells and suggest autoimmune modulation of the T cell receptor repertoire. bioRxiv 373555, doi: 10.1101/373555. [Google Scholar]
  • Overeem, S., Verschuuren, J.J., Fronczek, R., Schreurs, L., den Hertog, H., Hegeman-Kleinn, I.M., van Duinen, S.G., Unmehopa, U.A., Swaab, D.F., Lammers, G.J. (2006). Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. J Neuroimmunol, 174, 187-191. [CrossRef] [PubMed] [Google Scholar]
  • Overeem, S., Black, J.L., 3rd, Lammers, G.J. (2008). Narcolepsy: Immunological aspects. Sleep Med Rev, 12, 95-107 [CrossRef] [PubMed] [Google Scholar]
  • Partinen, M., Saarenpaa-Heikkila, O., Ilveskoski, I., Hublin, C., Linna, M., Olsen, P., Nokelainen, P., Alen, R., Wallden, T., Espo, M., Rusanen, H., Olme, J., Sätilä, H., Arikka, H., Kaipainen, P., Julkunen, I., Kirjavainen, T. (2012). Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One, 7, e33723. [CrossRef] [PubMed] [Google Scholar]
  • Pedersen, N.W., Holm, A., Kristensen, N.P., Bjerregaard, A.M., Bentzen, A.K., Marquard, A.M., Tamhane, T., Burgdorf, K.S., Ullum, H., Jennum, P., Knudsen, S., Hadrup, S.R., Kornum, B.R. (2019). CD8(+) T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun, 10, 837. [CrossRef] [PubMed] [Google Scholar]
  • Pelayo, R., Hodgson, N., Guilleminault, C. (2010). Chapter 34: the history of sleep medicine, Handbook of clinical neurology, 95, 547-556. [CrossRef] [PubMed] [Google Scholar]
  • Pelin, Z., Guilleminault, C., Risch, N., Grumet, F.C., Mignot, E. (1998). HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. Tissue Antigens, 51, 96-100. [PubMed] [Google Scholar]
  • Persson, I., Granath, F., Askling, J., Ludvigsson, J.F., Olsson, T., Feltelius, N. (2014). Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: A population- and registry-based cohort study with over 2 years of follow-up. J Intern Med, 275, 172-190. [Google Scholar]
  • Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., Li, R., Hungs, M., Pedrazzoli, M., Padigaru, M., Kucherlapati, M., Fan, J., Maki, R., Lammers, G.J., Bouras, C., Kucherlapati, R., Nishino, S., Mignot, E. (2000). A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med, 6, 991-997. [CrossRef] [PubMed] [Google Scholar]
  • Plazzi, G., Poli, F., Franceschini, C., Parmeggiani, A., Pirazzoli, P., Bernardi, F., Mignot, E., Cicognani, A., Montagna, P. (2008a). Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol, 255, 1549-1554. [CrossRef] [PubMed] [Google Scholar]
  • Plazzi, G., Serra, L., Ferri, R. (2008b). Nocturnal aspects of narcolepsy with cataplexy. Sleep Med Rev, 12, 109-128. [CrossRef] [PubMed] [Google Scholar]
  • Prinzmetal, M., Bloomberg, W. (1935). The use of benzedrine for the treatment of narcolepsy. J Am Med Assoc, 105, 2051-2054. [Google Scholar]
  • Rechtschaffen, A., Wolpert, E.A., Dement, W.C., Mitchell, S.A., Fisher, C. (1963). Nocturnal sleep of narcoleptics. Electroencephalogr Clin Neurophysiol, 15, 599-609. [CrossRef] [PubMed] [Google Scholar]
  • Rechtschaffen, A., Dement, W.C., Studies on the relation of narcolepsy, cataplexy and sleep with low voltage random EEG activity. In: S. Kety, E. Evarts, H. Williams, (Eds.), “Sleep and altered states of consciousness”, Williams and Wilkins, Baltimore, 1967, pp. 488-505. [Google Scholar]
  • Richardson, G.S., Carskadon, M.A., Flagg, W., Van den Hoed, J., Dement, W.C., Mitler, M.M. (1978). Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol, 45, 621-627. [CrossRef] [PubMed] [Google Scholar]
  • Ripley, B., Fujiki, N., Okura, M., Mignot, E., Nishino, S. (2001). Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol Dis, 8, 525-534. [CrossRef] [PubMed] [Google Scholar]
  • Roth, B., Nevsimalova, S., Sonka, K., Docekal, P., Schulz, H., Geisler, P., Pollmacher, T., Andreas-Zietz, A., Keller, E., Scholz, S., Albert, E., Ivaskova, E., Sajdlova, H., Kupkova, L. (1988). A study of occurrence of HLA DR2 in 124 narcoleptics: clinical aspects. Arch Suiss Neurol Psychiatr, 139, 41-51. [Google Scholar]
  • Rubin, R.L., Hajdukovich., R.M., Mitler, M.M. (1988). HLA DR2 association with excessive somnolence in narcolepsy does not generatize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clin Immun Immunipathol, 49, 149-158. [CrossRef] [Google Scholar]
  • Sakai, N., Matsumura, M., Lin, L., Mignot, E., Nishino, S. (2019). HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci Rep, 9, 477. [CrossRef] [PubMed] [Google Scholar]
  • Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S., Arch, J.R., Buckingham, R.E., Haynes, A.C., Carr, S.A., Annan, R.S., McNulty, D.E., Liu, W.S., Terrett, J.A., Elshourbagy, N.A., Bergsma, D.J., Yanagisawa, M. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 92, 573-585. [CrossRef] [PubMed] [Google Scholar]
  • Schenck, C.H., Bassetti, C.L., Arnulf, I., Mignot, E. (2007). English translations of the first clinical reports on narcolepsy and cataplexy by Westphal and Gélineau in the late 19th century, with commentary. J Clin Sleep Med, 3, 301-311. [PubMed] [Google Scholar]
  • Sharon, E., Sibener, L.V., Battle, A., Fraser, H.B., Garcia, K.C., Pritchard, J.K. (2016). Genetic variation in MHC proteins is associated with T cell receptor expression biases. Nat Genet, 48, 995-1002. [Google Scholar]
  • Shepard, J.W., Jr., Buysse, D.J., Chesson, A.L., Jr., Dement, W.C., Goldberg, R., Guilleminault, C., Harris, C.D., Iber, C., Mignot, E., Mitler, M.M., Moore, K.E., Phillips, B.A., Quan, S.F., Rosenberg, R.S., Roth, T., Schmidt, H.S., Silber, M.H., Walsh, J.K., White, D.P. (2005). History of the development of sleep medicine in the United States. J Clin Sleep Med, 1, 61-82. [PubMed] [Google Scholar]
  • Siebold, C., Hansen, B.E., Wyer, J.R., Harlos, K., Esnouf, R.E., Svejgaard, A., Bell, J.I., Strominger, J.L., Jones, E.Y., Fugger, L. (2004). Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A, 101, 1999-2004. [CrossRef] [PubMed] [Google Scholar]
  • Silber, M.H., Krahn, L.E., Olson, E.J., Pankratz, V.S. (2002). The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep, 25, 197-202. [PubMed] [Google Scholar]
  • Smith, A.J., Jackson, M.W., Neufing, P., McEvoy, R.D., Gordon, T.P. (2004). A functional autoantibody in narcolepsy. Lancet, 364, 2122-2124. [CrossRef] [PubMed] [Google Scholar]
  • Snider, L.A., Swedo, S.E. (2004). PANDAS: current status and directions for research. Mol Psychiatry, 9, 900-907. [CrossRef] [PubMed] [Google Scholar]
  • Symonds, C.P., Oxf, M.D., Lond, F.R.C.P. (1922). Narcolepsy as a symptom of encephalitis lethargica. Lancet, 173, 1214-1215. [Google Scholar]
  • Szakacs, A., Darin, N., Hallbook, T. (2013). Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology, 80, 1315-1321. [Google Scholar]
  • Tafti, M., Hor, H., Dauvilliers, Y., Lammers, G.J., Overeem, S., Mayer, G., Javidi, S., Iranzo, A., Santamaria, J., Peraita-Adrados, R., Vicario, J.L., Arnulf, I., Plazzi, G., Bayard, S., Poli, F., Pizza, F., Geisler, P., Wierzbicka, A., Bassetti, C.L., Mathis, J., Lecendreux, M., Donjacour, C.E., van der Heide, A., Heinzer, R., Haba-Rubio, J., Feketeova, E., Högl B., Frauscher, B., Benetó, A., Khatami, R., Cañellas, F., Pfister, C., Scholz, S., Billiard, M., Baumann, C.R., Ercilla, G., Verduijn, W., Claas, F.H., Dubois, V., Nowak, J., Eberhard, H.P., Pradervand, S., Hor, C.N., Testi, M., Tiercy, J.M., Kutalik, Z. (2014). DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep, 37, 19-25. [PubMed] [Google Scholar]
  • Tanaka, S., Honda, Y., Inoue, Y., Honda, M. (2006). Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep, 29, 633-638. [PubMed] [Google Scholar]
  • Taubenberger, J.K., Baltimore, D., Doherty, P.C., Markel, H., Morens, D.M., Webster, R.G., Wilson, I.A. (2012). Reconstruction of the 1918 influenza virus: unexpected rewards from the past. MBio, 3, e00201-12. [CrossRef] [PubMed] [Google Scholar]
  • Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., Siegel, J.M. (2000). Reduced number of hypocretin neurons in human narcolepsy. Neuron, 27, 469-474. [CrossRef] [PubMed] [Google Scholar]
  • Valko, P.O., Khatami, R., Baumann, C.R., Bassetti, C.L. (2008). No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J Neurol, 255, 1900-1903. [CrossRef] [PubMed] [Google Scholar]
  • Viboud, C., Simonsen, L. (2012). Global mortality of 2009 pandemic influenza A H1N1. Lancet Infect Dis, 12, 651-653. [CrossRef] [PubMed] [Google Scholar]
  • Vogel, G. (1960). Studies in psychophysiology of dreams III. The dream of narcolepsy. Arch Gen Psychiatry, 3, 421-428. [CrossRef] [PubMed] [Google Scholar]
  • Volkow, N.D., Fowler, J.S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.J., Jayne, M., Hooker, J.M., Wong, C., Hubbard, B., Carter, P., Warner, D., King, P., Shea, C., Xu, Y., Muench, L., Apelskog-Torres, K. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA, 301, 1148-1154. [CrossRef] [PubMed] [Google Scholar]
  • Von Economo, C. Encephalitis Lethargica, Humphrey Milford, Oxford University Press, London, 1931. [Google Scholar]
  • Wallenius, M., Lind, A., Akel, O., Karlsson, E., Svensson, M., Arvidsson, E., Ramelius, A., Törn, C., Palm, L., Lernmark, Å., Elding Larsson, H. (2019). Autoantibodies in Pandemrix®-induced narcolepsy: nine candidate autoantigens fail the conformational autoantibody test. Autoimmunity, 52, 185-191. [CrossRef] [PubMed] [Google Scholar]
  • Weiner Lachmi, K., Lin, L., Kornum, B.R., Rico, T., Lo, B., Aran, A., Mignot, E. (2012). DQB1*06:02 allele-specific expression varies by allelic dosage, not narcolepsy status. Hum Immunol, 73, 405-410. [CrossRef] [PubMed] [Google Scholar]
  • Westphal, C. (1877). Eigenthümliche mit Einschläfen verbundene Anfälle. Arch Psychiat, 7, 631-635. [Google Scholar]
  • Wijnans, L., Lecomte, C., de Vries, C., Weibel, D., Sammon, C., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Heijbel, H., Dahlstrom, L.A., Hallgren, J., Sparen, P., Jennum, P., Mosseveld, M., Schuemie, M., van der Maas, N., Partinen, M., Romio, S., Trotta, F., Santuccio, C., Menna, A., Plazzi, G., Moghadam, K.K., Ferro, S., Lammers, G.J., Overeem, S., Johansen, K., Kramarz, P., Bonhoeffer, J., Sturkenboom, M.C. (2013). The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic, and vaccination campaigns. Vaccine, 31, 1246-1254. [CrossRef] [PubMed] [Google Scholar]
  • Yoss, R.E., Daly, D.D. (1960). Narcolepsy. Med Clin North Am, 44, 953-968. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.